Mark Coyne
Impact in
- Rheumatology top 10%
- Spondyloarthritis Studies and Treatments
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
-
- Autoimmune and Inflammatory Disorders Research
Papers in
-
- Amyloidosis: Diagnosis, Treatment, Outcomes 7
- Protein Degradation and Inhibitors 1
- Oncology 4
- Co-authors
- Heather J. Cordell (1 shared paper)Lon R. Cardon (1 shared paper)B P Wordsworth (1 shared paper)Linda A. Bradbury (1 shared paper)Alison M. Crane (1 shared paper)Andrei Călin (1 shared paper)Matthew A. Brown (1 shared paper)Gordon W. Duff (1 shared paper)
- Journals
- Blood (2 papers)Cancers (1 paper)The American Journal of Human Genetics (1 paper)Arthritis & Rheumatology (1 paper)Advances in Therapy (1 paper)
- Partner nations
- United KingdomIrelandItaly
In The Last Decade
Mark Coyne
12 papers receiving 162 citations
Peers
Comparison fields: 5 of 44
- Rheumatology 86
- Hematology 39
- Immunology 49
- Nephrology 11
- Molecular Biology 78
Countries citing papers authored by Mark Coyne
This map shows the geographic impact of Mark Coyne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Coyne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Coyne more than expected).
Fields of papers citing papers by Mark Coyne
This network shows the impact of papers produced by Mark Coyne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Coyne. The network helps show where Mark Coyne may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Coyne, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 98 | |
| 2 | 2022 | 19 | |
| 3 | 2013 | 17 | |
| 4 | In vivo LE cell formation in peritonitis due to systemic lupus erythematosus. | 1974 | 12 |
| 5 | 2019 | 8 | |
| 6 | 2017 | 4 | |
| 7 | 2024 | 3 | |
| 8 | 2016 | 2 | |
| 9 | 2009 | 1 | |
| 10 | 2015 | 1 | |
| 11 | 2015 | 1 | |
| 12 | 2015 | 1 | |
| 13 | 2015 | 0 |
About Mark Coyne
Mark Coyne is a scholar working on Molecular Biology, Oncology, Hematology, Rheumatology and Genetics, having authored 13 papers that have together received 167 indexed citations. Recurring topics across this work include Amyloidosis: Diagnosis, Treatment, Outcomes (7 papers), Dermatological and Skeletal Disorders (3 papers), Parathyroid Disorders and Treatments (2 papers), Neuroendocrine Tumor Research Advances (2 papers), Multiple Myeloma Research and Treatments (2 papers), Cancer Genomics and Diagnostics (1 paper), Protein Degradation and Inhibitors (1 paper) and Microtubule and mitosis dynamics (1 paper). The work is most often cited by research in Rheumatology (86 citations), Hematology (39 citations), Immunology (49 citations), Nephrology (11 citations) and Molecular Biology (78 citations). Mark Coyne has collaborated with scholars based in United Kingdom, Ireland and Italy. Frequent co-authors include Heather J. Cordell, Lon R. Cardon, B P Wordsworth, Linda A. Bradbury, Alison M. Crane, Andrei Călin, Matthew A. Brown, Gordon W. Duff, Andrew E. Timms and Eun‐So Lee. Their work appears in journals such as Blood, Cancers, The American Journal of Human Genetics, Arthritis & Rheumatology and Advances in Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.